NEU neuren pharmaceuticals limited

2.40%

$17.09

Release Today Neuren Valuation Estimate Raised, page-71

First 71 Last

Share
Profile

Follow
lilypily

657 Posts.

32

09/03/18

10:10

Post #: 31640965
Share

Originally posted by acowell ↑

The P3 format agreed with the FDA is simple. As per the company announcement below endpoints and RSBQ have been agreed for one active dose group for a period of 6 months. To me we need to repeat what was already successful in P2 with a more accurate dosing regimen based on weight. IMO the success rates quoted in the above posts are very conservative.

"Neuren will conduct a single pivotal Phase 3 trial, using the Rett Syndrome Behaviour Questionnaire (RSBQ) and the Clinical Global Impression of Improvement (CGI-I) as co-primary efficacy endpoints. The double-blind, randomized, placebo-controlled trial will test one active dose group with a treatment duration of 6 months. The dosing regimen has been designed to achieve consistent drug exposure in subjects regardless of their weight. Neuren Executive Chairman Richard Treagus commented: “We are pleased to have held a very constructive meeting with the FDA Division of Neurology Products. It has provided necessary confirmation on the key issues relating to our proposed Phase 3 trial in Rett syndrome. We are now able to progress the final stages of development with full confidence. "

Expand

I agree I don’t think 57% is representative of neu COS. With blood test based dose titrations I think p3 is a home run .... but u just never know in bio weird things happen. I for one would take this calculated punt

Last edited by lilypily: 09/03/18

NEU Price at posting: $3.16 Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

LISTEN: HotCopper's Penny Drop Podcast #1 – Uranium deals, PFS misses, & an Ebola opportunity

HotCopper Highlights, Week 29: Dimerix licensing, lithium, & a Mesoblast milestone

Expert Exchange: Gold's record run (and a look at key risks) with David Sokulsky

PRU

Perseus pursues new growth opportunities at Yaoure gold mine

LISTEN: HotCopper Wire Podcast #052 – A big, juicy gold megamerger

Dale Gillham: The smoking gun hidden in Australia's jobs data

NNL

Nordic Resources further extends gold potential at Kopsa North

Australian resource exploration spending a 'mixed bag' on back of Middle East crisis

KAO

High-grade copper & tungsten results strengthen Karibib opportunity

RRE

Right observes high-grade tungsten from Blue metallurgical sample

First 71 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last $17.09		Change -0.420(2.40%)		Mkt cap ! $2.211B

Open	High	Low	Volume
$17.54	$17.56	$16.99	210.4K

Buyers (Bids)

Vol.	Price($)
1507	$16.97

Sellers (Offers)

Price($)	Vol.
$17.12	580

Last trade - 16.25pm 17/07/2026 (20 minute delay)

NEU (ASX) Chart

Release Today Neuren Valuation Estimate Raised, page-71

LISTEN: HotCopper's Penny Drop Podcast #1 – Uranium deals, PFS misses, & an Ebola opportunity

HotCopper Highlights, Week 29: Dimerix licensing, lithium, & a Mesoblast milestone

Expert Exchange: Gold's record run (and a look at key risks) with David Sokulsky

Perseus pursues new growth opportunities at Yaoure gold mine

LISTEN: HotCopper Wire Podcast #052 – A big, juicy gold megamerger

Dale Gillham: The smoking gun hidden in Australia's jobs data

Nordic Resources further extends gold potential at Kopsa North

Australian resource exploration spending a 'mixed bag' on back of Middle East crisis

High-grade copper & tungsten results strengthen Karibib opportunity

Right observes high-grade tungsten from Blue metallurgical sample

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Release Today Neuren Valuation Estimate Raised, page-71

Top Stories

LISTEN: HotCopper's Penny Drop Podcast #1 – Uranium deals, PFS misses, & an Ebola opportunity

HotCopper Highlights, Week 29: Dimerix licensing, lithium, & a Mesoblast milestone

Expert Exchange: Gold's record run (and a look at key risks) with David Sokulsky

Perseus pursues new growth opportunities at Yaoure gold mine

LISTEN: HotCopper Wire Podcast #052 – A big, juicy gold megamerger

Dale Gillham: The smoking gun hidden in Australia's jobs data

Nordic Resources further extends gold potential at Kopsa North

Australian resource exploration spending a 'mixed bag' on back of Middle East crisis

High-grade copper & tungsten results strengthen Karibib opportunity

Right observes high-grade tungsten from Blue metallurgical sample

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News